U.S. RESEARCH ROUNDUP-HCA Healthcare, Ncino, Progyny

Reuters12-02

Dec 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including HCA Healthcare, Ncino and Progyny, on Monday.

HIGHLIGHTS

* HCA Healthcare Inc : JP Morgan raises target price to $380

from $379

* Ncino Inc : KBW raises target price to $49 from $41

* Progyny Inc : JP Morgan cuts to neutral from overweight

Following is a summary of research actions on U.S. companies reported by Reuters on Monday. Stock entries are in alphabetical order.

* Ardent Health Partners Inc : JP Morgan raises target price to

$20 from $19

* HCA Healthcare Inc : JP Morgan raises target price to $380 from

$379

* Ncino Inc : KBW raises target price to $49 from $41

* Progyny Inc : JP Morgan cuts target price to $17 from $22

* Progyny Inc : JP Morgan cuts to neutral from overweight

* Tenet Healthcare Corp : JP Morgan raises target price to $175

from $172

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment